AA

Affinity Asset Advisors, LLC

13F
Affinity Asset Advisors, LLC
Last update 2025-05-15 95 Stocks (20 new)
Value $1.01 Bil Turnover 17 %
Countries:
Affinity Asset Advisors, LLC Top Holdings of 2025-03-31 View Full List
Ticker
SPY PUT
IWM PUT
XENE
APGE
XBI PUT
VRNA
ACLX
ALKS
NUVL
MDGL
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
SPY PUT
SPDR S&P 500 ETF Trust
400,000
223,756.0
0%
22.050
0%
0.040
+19.22%
+7.08%
643,289.7
 
IWM PUT
iShares Russell 2000 ETF
300,000
59,847.0
0%
5.900
0%
0.100
+19.22%
+0.62%
66,553.7
 
XENE
Xenon Pharmaceuticals Inc
1,328,175
44,560.3
+14.38%
4.390
+0.55%
1.730
-10.03%
-19.41%
2,424.0
Biotechnology
APGE
Apogee Therapeutics Inc
1,151,199
43,008.8
+23.56%
4.240
+0.81%
1.970
+18.73%
-13.22%
2,292.3
Biotechnology
XBI PUT
SPDR Biotech ETF
500,000
40,550.0
0%
4.000
0%
0.790
+13.63%
-4.19%
5,064.0
 
VRNA
Verona Pharma PLC
615,000
39,046.3
-6.82%
3.850
-0.30%
0.720
+78.04%
+125.88%
8,930.3
Biotechnology
ACLX
Arcellx Inc
530,000
34,768.0
+24.71%
3.430
+0.68%
0.960
+8.98%
-11.87%
3,724.7
Biotechnology
ALKS
Alkermes PLC
1,000,000
33,020.0
-9.09%
3.250
-0.41%
0.610
+8.22%
+1.60%
4,818.4
Drug Manufacturers
NUVL
Nuvalent Inc
460,000
32,623.2
+61.40%
3.210
+1.22%
0.640
+16.42%
+6.54%
5,988.9
Biotechnology
MDGL
Madrigal Pharmaceuticals Inc
80,000
26,498.4
-3.03%
2.610
-0.11%
0.360
+10.76%
+8.28%
7,418.8
Biotechnology

Affinity Asset Advisors, LLC's Historical Top Holdings Breakdowns

Affinity Asset Advisors, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
CRNX
Crinetics Pharmaceuticals Inc
2025-03-31
Reduce
Reduce
-2.25%
32.3 ($37.35) 53.15
$31.11
-16.71%
Reduce -66.9%
152,252
-307,748
ARVN
Arvinas Inc
2025-03-31
Sold Out
Sold Out
-1.73%
7.02 ($15.67) 20.5
$7.35
-53.10%
Sold Out
0
-630,000
SPY
SPDR S&P 500 ETF Trust
2025-03-31
New Buy
New Buy
+1.65%
551.42 ($587.78) 612.93
$627.58
6.77%
New holding
30,000
30,000
TVTX
Travere Therapeutics Inc
2025-03-31
Add
Add
+1.54%
17.07 ($20.3) 23.75
$16.11
-20.64%
Add 435%
1,070,000
870,000
PTGX
Protagonist Therapeutics Inc
2025-03-31
Add
Add
+1.29%
35.09 ($41.9) 59.76
$55.48
32.41%
Add 207.69%
400,000
270,000
NUVL
Nuvalent Inc
2025-03-31
Add
Add
+1.22%
67.38 ($78.19) 88.96
$83.40
6.66%
Add 61.4%
460,000
175,000
MLYS
Mineralys Therapeutics Inc
2025-03-31
Add
Add
+1.17%
8.76 ($11.5) 16.87
$14.23
23.74%
Add 214.29%
1,100,000
750,000
SYRE
Spyre Therapeutics Inc
2025-03-31
Reduce
Reduce
-1.14%
16.14 ($20.81) 24.42
$16.29
-21.72%
Reduce -41.57%
481,678
-342,650
APGE
Apogee Therapeutics Inc
2025-03-31
Add
Add
+0.81%
30.37 ($38.66) 49.57
$39.31
1.68%
Add 23.56%
1,151,199
219,471
ARWR
Arrowhead Pharmaceuticals Inc
2025-03-31
Sold Out
Sold Out
-0.81%
12.74 ($18.18) 21.53
$16.76
-7.81%
Sold Out
0
-300,000

Affinity Asset Advisors, LLC Total Holding History ($B)

To

Affinity Asset Advisors, LLC's Asset Allocation

To

Affinity Asset Advisors, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Affinity Asset Advisors, LLC's Hypothetical Growth since 2025-03-31

Affinity Asset Advisors, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Affinity Asset Advisors, LLC's Holdings Heat Map

Size field:

Affinity Asset Advisors, LLC's Holdings Bubble Chart

Affinity Asset Advisors, LLC News

  • 1

Discussions on Affinity Asset Advisors, LLC

No discussions yet.